Newsline

Newsline , Society

Congress Can Fix the Broken PBM Industry

Posted on Wednesday, February 14, 2024
|
by Outside Contributor
|
5 Comments
Pharmacy Bottles; PBM

Congress is in the process of negotiating a set of bipartisan health policies, including pharmacy benefit manager (PBM) reform. On the table for inclusion are two policies that will provide immediate relief for patients in the form of reduced out-of-pocket costs for drugs: delinking drug prices from PBM income and requiring PBMs to pass through the discounts, rebates and other price concessions they obtain from drug companies. PBM reform wouldn’t be complete without both reforms, as each is critically important in its own right.

Delinking will correct the perverse incentive behind seemingly absurd formulary decisions, like preferred coverage of a $10,000 brand drug while its $450 generic is not covered at all. Such a decision is rational from the PBM’s perspective because a $10,000 medication presents much higher income potential for the PBM, who negotiates percentage-based price concessions off that price point. 

When the group of medications is priced the same, this may not make much of a difference. Still, for medications with large price disparities, the one with the highest list price is the most attractive to the PBM. After all, even 1 percent of 10,000 is far better than 1 percent of 450. This is happening in Medicare Part D: a study found that the largest PBMs and insurers were driving Medicare beneficiaries who needed a drug for multiple sclerosis to the $8,275 brand rather than the $184 generic.

Since list prices seem mostly fictional, one might wonder whether any of this even matters. It does because patient cost-sharing is often tied to the list price, which leaves patients holding the bag for this perverse incentive. Delinking would stop this by severing the link between a PBM’s income and the price of a drug and moving PBMs to flat-fee compensation instead. As stewards of taxpayer-funded healthcare programs, lawmakers must correct perverse incentives that increase costs and reduce access for beneficiaries of those programs.

A pass-through is similarly essential. PBMs retain much of the price concessions they extract, which can be true even when their customers contractually require full pass-throughs. That came to light through litigations brought by different states against the PBMs who managed their state programs’ drug benefits. In Ohio, for example, the state auditor found in 2018 that a full 31 percent of the state’s generic drug spend was retained by PBMs. Subsequent litigation by states about this issue has resulted in large settlements. States should not have to file litigation to receive what was contractually due to them and their taxpayers. Similarly, the inspector general’s office in the Department of Health and Human Services has observed  that “many rebates do not flow through to consumers at the pharmacy counters.”

To obfuscate the money streams even more, the large PBMs have recently created subsidiary entities called “rebate aggregators,” some of which are organized offshore. If a PBM has such an affiliated entity, it can claim that the PBM passes through 100 percent of the rebates it receives without clarifying that most of the price concessions it negotiates accrue to its aggregator.

The lengths to which the PBM industry will go to avoid transparency as to the ultimate landing place of price concession dollars indicates who benefits from this system. Although delinking price concessions from PBM income will correct the incentive causing PBMs to prefer drugs with high list prices, negotiating discounts and constructing formularies will remain critical functions of a PBM, which means patients will still need help to access the price concessions negotiated by PBMs. For that reason, both reforms are critical.

As our patients and many healthcare colleagues know, the PBM industry is in dire need of reform. Delinking drug prices from PBM income and requiring PBMs to pass through discounts, rebates and other price concessions are critical steps in the right direction. 

These reforms would reduce out-of-pocket costs for patients, improve access to affordable medications, and create a more fair and transparent system for all stakeholders. Congress should act swiftly to pass these reforms into law and help ensure everyone has access to the prescription drugs they need at a price they can afford.

Robert Levin is the president of the Alliance for Transparent and Affordable Prescriptions. He wrote this for InsideSources.com.

Angus Worthing is the vice president of ATAP Action Network. He wrote this for InsideSources.com.

Reprinted with permission from DC Journal – By Robert Levin and Angus Worthing

The opinions expressed by columnists are their own and do not necessarily represent the views of AMAC or AMAC Action.

Share this article:
Subscribe
Notify of
guest
5 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
Kaiju
Kaiju
2 months ago

Congress/Government wants Government-run healthcare, which they can deliver if an angry consumer base demands government step in to “fix” the problem. Healthcare’s future is dictated more by Big Pharma than by government. Look into the unholy alliance between Big Pharma, Insurance companies and Government and the revolving door between them.

rvgrandma
rvgrandma
2 months ago

congress can fix a lot of what needs fixing if they would serve ALL the people, doing what is good for ALL Americans instead of just their party and those that put money in their bank accounts.

Deborah
Deborah
2 months ago

I agree something needs to be done. My copay for my MS medication under my Medicare Advantage plan is $1200 a MONTH! I am disabled on SSDI. How am I supposed to pay for that. And when the doctor prescribes a medication and says it is the only medication that will help, my insurance argues about it. Meanwhile, I keep suffering! (In this case, I had diarrhea for two years, lost a lot of weight and the doctor finally figured out something wrong in my colon. After a couple of months ai finally got Medication and the diarrhea stopped.

Stephen Russell
Stephen Russell
2 months ago

Use:
Incentives
Cut costs
CUT overhead
Reformulate plans
Use herbs, spices for healing
alone can Help

BOB
BOB
2 months ago

The problem is , if you don’t contribute , government does not care , they , congress ,D $ R , are all getting rich of these big companies .In my opinion that is the only reason to get elected .THey all become millionaires from getting greased to making shoddy deals .

An older blonde women laughing in the kitchen with a grey haired man.
AMAC’s Medicare Advisory Service
The knowledge, guidance, and choices of coverage you’re looking for. The exceptional service you deserve.
The AMAC App on 3 different iPhone
Download the AMAC App
The AMAC App is the place to go for insightful news wherever you are and whenever you want.
Joe Biden speaking with attendees
NEW YORK - OCT 10:American homeless sleeps in New York city subway on October 10 2009.A 2013 report show that the number of homeless people recorded in NYC topped 50,000 for the first time.
Former President of the United States Donald Trump speaking with attendees at the 2023 Turning Point Action Conference at the Palm Beach County Convention Center in West Palm Beach, Florida.
gen z and boomers; election - pick your side poster

Stay informed! Subscribe to our Daily Newsletter.

"*" indicates required fields

5
0
Would love your thoughts, please comment.x
()
x

Subscribe to AMAC Daily News and Games